Darren Jones

PFD Report Historic (No Identified Response)
Date of Report 27 November 2015
Coroner Heidi Connor
Coroner Area Nottinghamshire
Response Deadline est. 22 January 2016
Coroner's Concerns (AI summary)
The report identifies a need for review of protocols regarding when renal advice should be sought, especially for transplant patients, along with the education of staff and availability of immunosuppressant drugs.
Part of a Series

2 separate reports were issued from this inquest, each sent to different organisations.

  • 2022-0212
    Sent to: Greater Manchester Health and Social Care Partnership
    All responded

This report (None) is shown above.

Sent To
  • Burton Hospitals NHS Foundation Trust
Response Status
Linked responses 0 of 1
56-Day Deadline 22 Jan 2016
About PFD responses

Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.

Source: Courts and Tribunals Judiciary

Report Sections
Investigation and Inquest
On 3 July 2015, commenced an investigation into the death of Darren Jones, aged 42_ The investigation concluded at the end of the inquest on 19 November 2015. The conclusion of the inquest was natural causes The cause of death was 1a Massive left sided pleural and mediastinal haemorrhage_ 1b Perforation of the thoracic aorta_ Ic Invasive aspergillosis_ 2 Chronic kidney disease with renal transplant Iheard from several witnesses atinguest The Burton witnesses were ocum consultant physician, and locum consultant physician: reau InerStalement Iconsultant cardiolgist; onto the record:
Circumstances of the Death
Events leading to final admission Darren Jones was born on 15.11.72. His PMH included CKD, ankylosing spondylitis and a type of muscular dystrophy: He had a kidney transplant in 2009. He needed immunosuppressant medication after his transplant. We heard that Mr Jones started to show signs of organ rejection in late 2014. The evidence of Mr Jones' consultant nephrologist Ifrom Nottingham University Hospitals NHS Trust was that this may have been caused by the prescription of Adalimumab by rheumatologists at Burton earlier that year. She could not say that this was the most likely cause. The organ rejection may have been caused by several other factors. Mr Jones was admitted to hospital in December 2014 and treated for a Cryptosporidium infectionAfter that admission,he was seen by_his GP and at the understand plan that he would only consult Mr Jones' renal team when re-starting the medication levidence was that;, if she had been consulted, she would have advised that the medication should not be stopped I requested a copy of the trust's protocol and that of the Nottingham trust; to look specifically at what guidance there is to doctors at Burton on when to contact patients' renal teams. The protocol provided to me for Burton appears limited in that referral is only mandated where there is AKI stage 3, and no improvement after 24 hours of fluids The protocol does not deal with transplant patients.
2. Availability of immunosuppressant medication was advised at the inquest that the medication can now be obtained more quickly than within 24 hours. was not given more specific information about this_ and the experience of Dr Rabbani on 9 March was that the would take 24 hours to arrive_ be grateful if you would consider the following points arising out of this inquest A review of current protocols regarding when renal advice should be sought for patients particularly those who have undergone transplants_ appreciate that the usual renal team for patients in Burton would be based in Derby. Education and sharing of new protocols that are created, to all relevant staff. Availability of immunosuppressant drugs at short notice
Action Should Be Taken
In my opinion action should be taken to prevent future deaths and believe you have the power to take such action:
Related Inquiry Recommendations

Public inquiry recommendations addressing similar themes

Investigations
Mid Staffs Inquiry
Patient safety governance Clinical negligence harms learning
Use of information about compliance by regulator from: Media
Mid Staffs Inquiry
Patient safety governance Clinical negligence harms learning
NHS Litigation Authority Improvement of risk management
Mid Staffs Inquiry
Patient safety governance Clinical negligence harms learning
NHS Litigation Authority Improvement of risk management
Mid Staffs Inquiry
Patient safety governance Clinical negligence harms learning
NHS Litigation Authority Improvement of risk management
Mid Staffs Inquiry
Patient safety governance Clinical negligence harms learning
Evidence-based assessment
Mid Staffs Inquiry
Patient safety governance Clinical negligence harms learning
Information sharing
Mid Staffs Inquiry
Patient safety governance Clinical negligence harms learning
IPC Structures and Transmission Risk
COVID-19 Inquiry
Patient safety governance
ICU Resource Allocation Framework
COVID-19 Inquiry
Patient safety governance
HTA require anatomy adverse incidents reported as HTARIs
Fuller Inquiry
Patient safety governance

Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.